| Chemical Week |
| June 9,1999 |
| Custom Manufacturers Find Their Niche.(CW Fine and Custom Chemicals Conference and Expo) |
| Author/s: Samuel K. Moore |
| Competition for
outsourcing deals, particularly in the fast-growing pharmaceuticals
sector, is further stratifying the custom manufacturing industry,
according to attendees at the CW Fine and Custom Chemicals Conference
and Expo in Baltimore last month. Large fine chemical firms are becoming as
important a customer group as pharmaceutical firms for smaller, niche
fine chemicals suppliers. Conference speakers say the large fine
chemical companies are beginning to control the flow of contracts to
niche producers. Christian Leemann, business director/bulk
pharmaceuticals and intermediates at Algroup Lonza, estimates that the
leading 30-40 fine chemical companies compete to make about 15 new
pharmaceuticals and pesticides every year. Leemann says that lopsided
ratio is accelerating consolidation. "Custom synthesis is still
considered a cottage industry," he says. "But size does
matter." He suggests $200 million/year as the minimum size for a
company to be competitive in fine chemicals for life science. Cameron Reid, president of Reddy-Cheminor
(Hyderabad, India), says consolidation dominates India's fine and custom
chemicals industry. "The future of the industry is M&A, and
those that are not candidates will become extinct," Reid says. Major toll and custom producers,
particularly those involved in manufacturing for the pharmaceuticals
industry, are adding to their capabilities. AlliedSignal has been
expanding its newly acquired plants at Arklow, Ireland and Freeport, the
Bahamas. At Freeport, Allied is installing a cryogenic reactor to
attract drugs business. Catalytica continues its efforts to
become a single source for pharmaceuticals customers. James Cusumano,
chairman of Catalytica, says he wants to double sales to $1 billion in
the next five years through organic growth and acquisitions. The company
recently strengthened its formulation capabilities, adding sterile
dosage lines at Greenville, NC. Catalytica also plans to add to its
biotechnology and fermentation capabilities (CW, April 21, p. 25). Mergers and acquisitions have beefed up
other custom manufacturers. Dow has pushed Hampshire Chemical, which it
purchased two years ago, to aggressively pursue custom contracts, says
Leo J. Thielman, leader/corporate development and market research at
Hampshire. Thielman says that before the acquisition, Hampshire merely
responded to customers seeking suppliers. "We tended to be
reactive," he says. "Now we are consciously trying to partner
with companies in pharmaceuticals, agrochemicals, and personal care at
early stages." Other recent M&A deals include
Laporte's purchase of Inspec last year and this year's purchase of
Haltermann by Ascot (London)-parent of Chemoxy International and
Pentagon Chemicals. Still, custom
manufacturers intent on building broad technology platforms stress that
opportunities remain for a "second tier" of niche suppliers.
Leemann says these suppliers will have a regional customer base and will
take work outsourced by the industry leaders as these bigger players
shift toward services such as process development. Edward Richman,
president of Richman Chemicals (Lower Gwynedd, PA), says this model also
benefits firms such as his that specialize in outsourcing management. Small suppliers say
they have always benefitted from subcontracting. "We've had some
opportunities to do pharmaceutical intermediates on a spot basis,"
says Frank LaMonica, general manager for custom producer Cymer (Decatur,
TN). "We mostly come in to get people out of a jam." Specialized niche chemistries help small
manufacturers survive among giants, according to Val Krukonis, president
of Phasex (Lawrence, MA), which specializes in supercritical fluids
extraction. Krukonis says there is no danger of large companies getting
into his field because it is too small. Bob Kopki, contract manufacturing manager
at Mobil Chemical, says this does not mean large companies cannot
compete in custom manufacturing. He says his division acts as a small,
entrepreneurial business. "In that regard, we're not all that much
different [from smaller companies], though I suspect our equipment is
bigger." Mobil and Lubrizol are among the giants
using their excess capacity to form custom manufacturing ventures. Mobil
is offering to toll a variety of products, including esters and olefins,
at Edison, NJ; Beaumont, TX; and Amsterdam. Lubrizol is tolling organic
specialties at Painesville, OH. More producers may follow. Mallinckrodt
Baker (Phillipsburg, NJ) may parlay its analytical chemistry skills into
a fine and custom chemicals business, says Herman J. Mitchell, senior
business manager/chromatography products. Eui-Won Choe, technology
consultant for petrochemical and pharmaceutical intermediates maker ISU
Chemical (Seoul), says ISU is looking for a joint venture partner to
market its services in the U.S. |
Copyright 1999 Chemical Week Associates in association with The Gale Group and LookSmart.